AI assistant
10x Genomics, Inc. — Director's Dealing 2021
Aug 26, 2021
31830_dirs_2021-08-25_0629d1f6-d82f-416e-9fb7-813528af4484.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: 10x Genomics, Inc. (TXG)
CIK: 0001770787
Period of Report: 2021-08-23
Reporting Person: Kosaraju Sridhar (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-08-23 | Class A Common Stock | S | 200 | $157.715 | Disposed | 10300 | Indirect |
| 2021-08-23 | Class A Common Stock | S | 100 | $160.56 | Disposed | 10200 | Indirect |
| 2021-08-23 | Class A Common Stock | S | 500 | $162.27 | Disposed | 9700 | Indirect |
| 2021-08-23 | Class A Common Stock | S | 600 | $163.2475 | Disposed | 9100 | Indirect |
| 2021-08-23 | Class A Common Stock | S | 100 | $164.05 | Disposed | 9000 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 3458 | Direct |
Footnotes
F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan entered into by the Kosaraju Family Trust dated June 21, 2014, of which the Reporting Person is trustee (the "Kosaraju Family Trust").
F2: This transaction was executed in multiple trades at prices ranging from $157.32 to $158.11. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F3: These shares are held by the Kosaraju Family Trust.
F4: This transaction was executed in multiple trades at prices ranging from $161.66 to $162.51. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.
F5: This transaction was executed in multiple trades at prices ranging from $162.90 to $163.68. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.